Annexon, Inc. (ANNX) — Stock Score Summary

Annexon, Inc. (ANNX) has a MoatMap StockRank of 37/100 based on Quality (30/100), Value (35/100), and Momentum (59/100) factor scores. The current signal is HOLD. Annexon is a clinical-stage biotech company with no commercialized products, high cash burn, and binary clinical trial risks, failing our quality and margin of safety requirements.

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing novel C1q and classical complement pathway inhibitors to treat a range of autoimmune, neurodegenerative, and ophthalmic diseases. The company's proprietary antibody platform targets a specific component of the immune system, aiming to halt disease progression by preventing complement-mediated damage. Its competitive edge lies in its pioneering scientific approach to complement biology and the potential breadth of its therapeutic applications.

Key Financial Metrics

Price$5.20
Market Cap$880M
P/E (Forward)-5.90
Price/Book4.33
Return on Equity-87.6%
Return on Invested Capital-92.1%
Debt/Equity12.44
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-107M

Annexon, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Annexon, Inc.’s (ANNX) StockRank?
MoatMap’s StockRank for Annexon, Inc. (ANNX) is 37/100, with a Hold signal. It is a composite of Quality (30), Value (35), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Annexon, Inc. have an economic moat?
Annexon, Inc. (ANNX) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Annexon, Inc. a buy, hold, or sell?
MoatMap’s current signal for Annexon, Inc. (ANNX) is Hold, based on a StockRank of 37/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Annexon, Inc. in?
Annexon, Inc. (ANNX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANNX deep dive reportAI ChampionsHow we score stocksSense-check another stock